Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,967 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease

NCT03036852

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Kaye Edmonton Clinic Edmonton, Alberta, Canada
  • Gordon and Leslie Diamond Health Care Center, Vancouver General Hospital, UBC Division of Gastroenterology Vancouver, British Columbia, Canada
  • William Osler Health System- Brampton Civic Hospital Brampton, Ontario, Canada
View all 22 locations
View Trial Details
Completed

TAF for HIV-HBV With Renal Dysfunction

NCT03115736

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +16 more
Locations
  • Kantonsspital St. Gallen Sankt Gallen, Canton of St. Gallen, Switzerland
  • Cabinet médical Chave-Crottaz-Roggerto Lausanne, Canton of Vaud, Switzerland
  • Ospedale Regionale di Lugano Lugano, Canton Ticino, Switzerland
  • Centre hospitalier universitaire vaudois (CHUV) Lausanne, Vaude, Switzerland
View Trial Details
Completed

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection

NCT02378961

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • Huntington Memorial Hospital Liver Center Pasadena, California, United States
  • Medical Associates Research Group, Inc. San Diego, California, United States
View all 34 locations
View Trial Details
Completed

Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease

NCT03036839

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • James J. Peters VA Hospital The Bronx, New York, United States
  • The Liver Institute at Methodist Dallas Medical Center Dallas, Texas, United States
View all 21 locations
View Trial Details
Completed

Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis

NCT02994056

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Tampa General Medical Group Tampa, Florida, United States
  • Northwestern Memorial Hospital; Clinical Research Unit Chicago, Illinois, United States
  • Digestive Disease Associates, PA Catonsville, Maryland, United States
  • Southern Therapy and Advanced Research LLC Jackson, Mississippi, United States
View Trial Details

Related conditions